Asterias stem cell therapy shows promise in spinal cord paralysis: US st… – Reuters
The Express Tribune |
Asterias stem cell therapy shows promise in spinal cord paralysis: US st…
Reuters The company had not expected to reach the efficacy goal before six to 12 months after implantation of the 10 million embryonic stem cells dubbed AST-OPC1, Asterias Chief Executive Stephen Cartt said. "We came out early with the data because it was so … What We're Looking For From The Upcoming Asterias Biotherapeutics Inc (NYSEMKT:AST) Presentation |
